Genomic studies to unlock
the truth of active compounds
Genel provides pharmaceutical and cosmetic companies
with new services to enhance personalized care.
Genel proposes innovative approach:
using 3D cellular models and primary cells to highlight active ingredient effects on its gene target
combining bioscreening, new imaging system and bioinformatics to guarantee an effective, fast, reliable and ready-to-use result
The Genel team will be attending the final conference of PERMIDES European project the next week!
Utrecht, The Netherlands | 12-13 June 2018
Our CEO, Gaëlle SAINT-AURET has been selected as speaker for our Innovative Screening Process for the Development of Personalized Anticancer Treatment. This...
GENEL présente à ADEBIOTECH 2018
Romainville-Grand Paris | 13-14 March 2018
Gaëlle Saint-Auret présente à ADEBIOTECH les 13 et 14 Mars prochain. Elle y discutera des outils d'intérêt pour l'étude de l'épigénétique.
genel at In-Cosmetics
London, UK | 4-6 April 2017
Let us meet at ExCel London! The genel team will be present at this major event and hope to meet you there!
Join the team as a Technical Sales Engineer!
Grenoble | 30 May 2018
We are looking for a science-driven sales engineer for the team! Got what it takes? Send us your application!
Explore our most recent innovations : genERGY & genSPECTRA!
Grenoble | 15 April 2018
Discover new tests from GENEL: Compelling ways of analysing how mitochondria are boosted by an active ingredient and a unique method to study the effects of...
GENEL and BASF granted a podium session in New York
Grenoble | 21 March 2018
BASF presented results of another fruitful collaboration with GENEL at the podium sessions of the 71st Annual Scientific Meeting & Technology Showcase in New...
The key to performance
